Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Necitumumab |
Trade Name | Portrazza |
Synonyms | IMC-11F8 |
Drug Descriptions |
Portrazza (necitumumab) is a fully human IgG1 mAb targeting EGFR, leading to the inhibition of downstream targets in the EGFR pathway, and thereby inhibiting cellular proliferation and invasion (PMID: 21154125). Portrazza (necitumumab) is approved for patients with metastatic squamous non-small cell lung cancer (FDA.gov). |
DrugClasses | EGFR Antibody 60 |
CAS Registry Number | 906805-06-9 |
NCIT ID | C88281 |